http://www.biotec.no/biotec-pharmacon/category2.html2009-01-30T12:10:18+01:000.2http://www.biotec.no/biotec-pharmacon/logo-article480-2.html2008-11-30T22:37:23+01:000.2http://www.biotec.no/biotec-pharmacon/about-biotec-pharmacon-article511-2.html2010-05-03T11:27:04+02:000.2http://www.biotec.no/company-profile/category50.html0.2http://www.biotec.no/company-profile/biotec-pharmacon-article20-50.html2009-03-24T19:55:34+01:000.2http://www.biotec.no/vision/category51.html0.2http://www.biotec.no/vision/company-vision-and-business-idea-article13-51.html2009-03-24T20:24:05+01:000.2http://www.biotec.no/history/category52.html0.2http://www.biotec.no/history/company-history-article24-52.html2009-03-25T12:49:32+01:000.2http://www.biotec.no/facilities/category54.html0.2http://www.biotec.no/facilities/production-facilities-article32-54.html2009-04-02T09:15:21+02:000.2http://www.biotec.no/intellectual-property-rights/category84.html0.2http://www.biotec.no/news/patent-granted-in-usa-article665-18.html2010-05-28T12:50:48+02:000.2http://www.biotec.no/intellectual-property-rights/intellectual-property-rights-article52-84.html2010-02-22T08:34:45+01:000.2http://www.biotec.no/patents-for-licensing/category131.html0.2http://www.biotec.no/patents-for-licensing/bioactive-peptides-for-enhancement-of-weight-in-animals-article118-131.html2005-05-13T11:10:22+02:000.2http://www.biotec.no/patents-for-licensing/derivatized-immunemodulating-carbohydrates-article121-131.html2005-05-11T11:39:57+02:000.2http://www.biotec.no/trademarks-for-licensing/category132.html0.2http://www.biotec.no/trademarks-for-licensing/peptigard-article122-132.html2005-05-09T14:10:39+02:000.2http://www.biotec.no/subsidiaries/category95.html0.2http://www.biotec.no/subsidiaries/subsidiaries-article573-95.html2010-04-09T15:54:22+02:000.2http://www.biotec.no/research/category338.html2009-01-30T12:11:07+01:000.2http://www.biotec.no/research/pharmaceutical-concept-article508-338.html2008-01-02T14:02:34+01:000.2http://www.biotec.no/product-pipeline/clinical-development-program-article509-90.html2008-01-02T15:38:54+01:000.2http://www.biotec.no/research/technology-platform-for-sbg-article510-338.html2008-01-02T15:41:15+01:000.2http://www.biotec.no/background-beta-glucans/category96.html0.2http://www.biotec.no/facts-on-beta-glucan/background-on-beta-1-3-1-6-glucan-products-article25-86.html2009-03-25T13:17:33+01:000.2http://www.biotec.no/background-enzymes/category97.html0.2http://www.biotec.no/life-science/cold-adapted-marine-enzymes-article51-9.html2010-05-03T11:20:19+02:000.2http://www.biotec.no/pharmaceutical-development/category10.html2009-04-02T10:39:01+02:000.2http://www.biotec.no/pharmaceutical-development/pharmaceutical-development-article620-10.html2010-04-15T13:18:02+02:000.2http://www.biotec.no/scientific-background/category22.html0.2http://www.biotec.no/scientific-background/pharmaceutical-development-article307-22.html2006-05-16T15:27:08+02:000.2http://www.biotec.no/facts-on-beta-glucan/category86.html0.2http://www.biotec.no/facts-on-beta-glucan/background-on-beta-1-3-1-6-glucan-products-article25-86.html2009-03-25T13:17:33+01:000.2http://www.biotec.no/facts-on-beta-glucan/soluble-beta-1-3-1-6-glucan-sbg-article27-86.html2005-04-18T11:29:19+02:000.2http://www.biotec.no/r-d/category48.html0.2http://www.biotec.no/facts-on-beta-glucan/soluble-beta-1-3-1-6-glucan-sbg-article27-86.html2005-04-18T11:29:19+02:000.2http://www.biotec.no/life-science/category9.html0.2http://www.biotec.no/news/the-cold-rush-article627-18.html2009-08-28T11:11:55+02:000.2http://www.biotec.no/life-science/cold-adapted-marine-enzymes-article51-9.html2010-05-03T11:20:19+02:000.2http://www.biotec.no/products/category5.html0.2http://www.biotec.no/shrimp-alkaline-phosphatase-sap/shrimp-alkaline-phosphatase-sap-article83-81.html2009-04-02T11:26:54+02:000.2http://www.biotec.no/shrimp-nuclease/shrimp-nuclease-recombinant-article46-82.html2009-04-17T11:10:55+02:000.2http://www.biotec.no/uracil-dna-n-glycosylase-cod-ung/cod-uracil-dna-n-glycosylase-cod-ung-article36-83.html2009-04-02T11:37:46+02:000.2http://www.biotec.no/r-d/category21.html0.2http://www.biotec.no/partners/category6.html0.2http://www.biotec.no/product-pipeline/category90.html0.2http://www.biotec.no/product-pipeline/diabetic-foot-ulcer-fact-sheet-article603-90.html2009-04-02T08:40:53+02:000.2http://www.biotec.no/product-pipeline/clinical-development-program-article509-90.html2008-01-02T15:38:54+01:000.2http://www.biotec.no/bioprospecting/category99.html0.2http://www.biotec.no/news/the-cold-rush-article627-18.html2009-08-28T11:11:55+02:000.2http://www.biotec.no/products/category58.html2009-01-30T12:10:29+01:000.2http://www.biotec.no/products/main-product-groups-article15-58.html2010-05-03T11:16:39+02:000.2http://www.biotec.no/consumer-products/category68.html0.2http://www.biotec.no/consumer-products/consumer-health-products-article505-68.html2007-12-03T13:53:34+01:000.2http://www.biotec.no/consumer-products/nbg-norwegian-beta-glucan-article49-68.html2009-03-24T20:37:43+01:000.2http://www.biotec.no/life-science-products/category70.html0.2http://www.biotec.no/life-science/cold-adapted-marine-enzymes-article51-9.html2010-05-03T11:20:19+02:000.2http://www.biotec.no/shrimp-alkaline-phosphatase-sap/category81.html0.2http://www.biotec.no/shrimp-alkaline-phosphatase-sap/shrimp-alkaline-phosphatase-sap-article83-81.html2009-04-02T11:26:54+02:000.2http://www.biotec.no/shrimp-nuclease/category82.html0.2http://www.biotec.no/shrimp-nuclease/shrimp-nuclease-recombinant-article46-82.html2009-04-17T11:10:55+02:000.2http://www.biotec.no/uracil-dna-n-glycosylase-cod-ung/category83.html0.2http://www.biotec.no/uracil-dna-n-glycosylase-cod-ung/cod-uracil-dna-n-glycosylase-cod-ung-article36-83.html2009-04-02T11:37:46+02:000.2http://www.biotec.no/news/category18.html2009-01-30T12:10:38+01:000.2http://www.biotec.no/news/trond-giske-to-visit-biotec-pharmacon-subsidiary-article671-18.html2010-09-02T15:24:51+02:000.2http://www.biotec.no/financial-calendar/q2-2010-presentation-as-webcast-article669-175.html2010-08-05T12:49:25+02:000.2http://www.biotec.no/news/patent-granted-in-usa-article665-18.html2010-05-28T12:50:48+02:000.2http://www.biotec.no/financial-calendar/q1-2010-presentation-as-webcast-article663-175.html2010-05-07T17:20:23+02:000.2http://www.biotec.no/news/ordinary-general-meeting-article661-18.html2010-04-13T15:00:38+02:000.2http://www.biotec.no/news/biotec-marine-biochemicals-reviewed-in-pcr-insider-the-leading-journal-for-pcr-users-article659-18.html2010-04-09T16:04:48+02:000.2http://www.biotec.no/news/svein-lien-appointed-new-ceo-of-biotec-pharmacon-asa-article657-18.html2010-03-10T14:33:15+01:000.2http://www.biotec.no/news/biotec-pharmacon-presenting-re-established-platform-at-bio-europe-2010-article656-18.html2010-03-10T14:43:32+01:000.2http://www.biotec.no/news/testing-sbg-packaging-containers-after-weak-results-from-oral-mucositis-study-article651-18.html2010-02-22T08:28:16+01:000.2http://www.biotec.no/news/extraordinary-general-meeting-article649-18.html2010-01-11T13:36:36+01:000.2http://www.biotec.no/news/biotec-pharmacon-to-focus-on-bio-pharmaceuticals-sells-immunocorp-consumer-health-as-article650-18.html2009-12-30T14:33:10+01:000.2http://www.biotec.no/news/biotec-pharmacon-realigns-strategy-and-reduces-workforce-article647-18.html2009-12-11T08:00:00+01:000.2http://www.biotec.no/news/phase-iii-results-with-sbg-for-diabetic-foot-ulcer-not-positive-article646-18.html2009-11-23T07:30:00+01:000.2http://www.biotec.no/news/databases-locked-in-both-the-phase-iii-clinical-studies-with-sbg-for-diabetic-foot-ulcer-article644-18.html2009-11-03T10:14:08+01:000.2http://www.biotec.no/news/presenting-at-bio-investor-forum-in-san-francisco-and-at-bio-europe-2009-in-vienna-article642-18.html2009-10-28T13:58:08+01:000.2http://www.biotec.no/news/3q-presentation-as-webcast-article640-18.html2009-10-23T08:47:06+02:000.2http://www.biotec.no/news/presenting-at-life-science-conference-in-new-york-and-at-bio-business-seminar-in-zurich-article635-18.html2009-09-24T08:56:01+02:000.2http://www.biotec.no/news/biotec-pharmacon-at-both-biotech-in-europe-and-biopharm-america-in-september-article632-18.html2009-09-11T08:30:00+02:000.2http://www.biotec.no/news/completed-patient-inclusion-in-phase-iii-study-for-oral-mucositis-article631-18.html2009-09-08T13:03:34+02:000.2http://www.biotec.no/news/biotec-pharmacon-presents-its-cancer-program-at-eccp-in-toulouse-article628-18.html2009-09-03T12:53:41+02:000.2http://www.biotec.no/news/the-cold-rush-article627-18.html2009-08-28T11:11:55+02:000.2http://www.biotec.no/news/settlement-between-biotec-pharmacon-asa-and-biothera-article626-18.html2009-08-17T08:33:10+02:000.2http://www.biotec.no/news/phase-iii-oral-mucositis-study-proceeds-as-planned-after-interim-analysis-article625-18.html2009-08-10T11:30:52+02:000.2http://www.biotec.no/news/u-s-patent-court-case-scheduled-for-14-september-2009-article623-18.html2009-07-16T08:52:24+02:000.2http://www.biotec.no/news/jan-buch-andersen-heading-up-newly-established-biotec-marine-biochemicals-as-article622-18.html2009-06-17T08:56:26+02:000.2http://www.biotec.no/news/phase-iii-diabetic-ulcer-program-proceeds-as-planned-after-interim-analysis-article621-18.html2009-05-11T15:00:03+02:000.2http://www.biotec.no/news/completed-patient-inclusion-in-both-phase-iii-diabetic-ulcer-studies-article619-18.html2009-04-02T08:42:16+02:000.2http://www.biotec.no/news/completed-patient-inclusion-in-the-first-phase-iii-diabetic-ulcer-study-article604-18.html2009-03-17T16:33:24+01:000.2http://www.biotec.no/news/biotec-pharmacon-at-bio-europe-spring-2009-in-milan-article597-18.html2009-03-09T12:46:58+01:000.2http://www.biotec.no/www-biotec-as/u-s-district-court-confirms-positive-patent-case-ruling-in-favour-of-biotec-pharmacon-article595-1.html2009-03-04T09:52:55+01:000.2http://www.biotec.no/www-biotec-as/presentation-at-bio-ceo-investor-conference-in-new-york-february-9th-2009-article594-1.html2009-03-04T09:50:53+01:000.2http://www.biotec.no/www-biotec-as/favourable-ruling-for-biotec-pharmacon-in-u-s-patent-case-article589-1.html2009-03-04T09:21:36+01:000.2http://www.biotec.no/www-biotec-as/clinical-program-update-article588-1.html2009-03-04T09:19:25+01:000.2http://www.biotec.no/www-biotec-as/started-cod-ung-deliveries-to-siemens-healthcare-diagnostics-article587-1.html2009-03-04T09:06:55+01:000.2http://www.biotec.no/www-biotec-as/diabetic-ulcers-phase-iii-program-continues-as-planned-after-interim-analysis-article584-1.html2009-03-04T08:46:28+01:000.2http://www.biotec.no/www-biotec-as/patient-inclusion-started-in-second-phase-iii-diabetic-ulcer-study-article583-1.html2009-03-03T15:58:07+01:000.2http://www.biotec.no/www-biotec-as/patient-inclusion-started-in-phase-iii-oral-mucositis-study-article582-1.html2009-03-03T15:56:06+01:000.2http://www.biotec.no/www-biotec-as/dr-sven-rohmann-46-joins-biotec-pharmacon-asa-as-vice-president-business-development-article581-1.html2009-03-03T15:54:02+01:000.2http://www.biotec.no/www-biotec-as/biotec-pharmacon-asa-selger-immunocorp-animal-health-as-article580-1.html2009-03-03T15:51:52+01:000.2http://www.biotec.no/www-biotec-as/biotec-pharmacon-rendyrker-bio-farmasoeytisk-virksomhet-selger-immunocorp-animal-health-article578-1.html2009-03-03T15:46:44+01:000.2http://www.biotec.no/www-biotec-as/poster-fra-sloan-kettering-studie-presentert-paa-neuroblastoma-forskningskonferanse-i-koyoto-article596-1.html2009-03-04T09:58:29+01:000.2http://www.biotec.no/news/rapport-fra-sloan-kettering-studien-article512-18.html2008-01-16T10:07:50+01:000.2http://www.biotec.no/www-biotec-as/leveranseavtale-for-cod-ung-article575-1.html2009-03-03T15:14:41+01:000.2http://www.biotec.no/news/preliminary-results-from-the-sloan-kettering-clinical-study-article500-18.html2007-11-23T13:02:19+01:000.2http://www.biotec.no/news/completed-share-issue-and-sale-of-treasury-shares-article499-18.html2007-11-23T12:50:36+01:000.2http://www.biotec.no/news/contemplated-directed-equity-issue-article498-18.html2007-11-20T16:07:21+01:000.2http://www.biotec.no/news/biotec-pharmacon-enters-phase-iii-with-the-oral-mucositis-indication-article496-18.html2007-11-20T15:20:01+01:000.2http://www.biotec.no/news/biotec-pharmacon-enters-phase-iii-with-the-diabetic-ulcers-indication-article497-18.html2007-11-20T15:20:31+01:000.2http://www.biotec.no/news/biotec-pharmacon-kommersiell-partner-i-senter-for-forskningsdrevet-innovasjon-i-tromsoe-article479-18.html2007-05-11T10:10:59+02:000.2http://www.biotec.no/news/poster-presentation-at-chi-s-3rd-annual-qpcr-conference-article467-18.html2007-05-11T10:04:56+02:000.2http://www.biotec.no/news/positive-resultater-fra-diabetessaarstudien-article324-18.html2006-10-13T08:19:32+02:000.2http://www.biotec.no/news/positive-resultater-fra-oral-mukosittstudien-article323-18.html2007-09-10T10:26:20+02:000.2http://www.biotec.no/news/biotec-pharmacon-completes-patient-enrollment-in-phase-ii-clinical-trial-for-treatment-of-diabetic-ulcers-article306-18.html2006-05-16T13:51:10+02:000.2http://www.biotec.no/news/good-progress-in-ongoing-clinical-trials-article239-18.html2006-02-28T08:21:58+01:000.2http://www.biotec.no/news/new-clinical-study-for-treatment-of-diabetic-foot-ulcers-article238-18.html2006-02-24T12:49:42+01:000.2http://www.biotec.no/news/biotec-pharmacon-to-trial-sbg-rituxan-combination-therapy-at-the-radium-hospital-article224-18.html2005-12-02T16:07:42+01:000.2http://www.biotec.no/news/biotec-pharmacon-to-start-sbg-trials-with-herceptin-article229-18.html2005-12-02T16:16:35+01:000.2http://www.biotec.no/archive-links/category120.html0.2http://www.biotec.no/archive-links/archive-links-article88-120.html2005-10-31T15:41:05+01:000.2http://www.biotec.no/investors/category57.html2009-01-30T12:10:46+01:000.2http://www.biotec.no/investors/share-information-article198-57.html2009-03-25T13:26:10+01:000.2http://www.biotec.no/largest-shareholders/category93.html2009-03-18T14:34:33+01:000.2http://www.biotec.no/largest-shareholders/largest-shareholders-article615-93.html2010-09-03T18:34:59+02:000.2http://www.biotec.no/stock-exchange-announcements/category94.html0.2http://www.biotec.no/stock-exchange-announcements/links-to-newsweb-at-oslo-boers-article146-94.html2009-09-30T14:16:55+02:000.2http://www.biotec.no/share-information/category156.html0.2http://www.biotec.no/investors/share-information-article198-57.html2009-03-25T13:26:10+01:000.2http://www.biotec.no/risk/category216.html0.2http://www.biotec.no/risk/risk-beloep-article328-216.html2006-11-23T09:51:28+01:000.2http://www.biotec.no/corporate-information/category157.html0.2http://www.biotec.no/corporate-information/corporate-information-article502-157.html2010-04-06T10:06:10+02:000.2http://www.biotec.no/board-of-directors/category159.html2009-03-18T13:05:50+01:000.2http://www.biotec.no/board-of-directors/board-of-directors-article612-159.html2010-06-15T10:26:39+02:000.2http://www.biotec.no/management/category158.html2010-04-06T10:01:35+02:000.2http://www.biotec.no/management/management-article658-158.html2010-09-03T18:24:42+02:000.2http://www.biotec.no/articles-of-association/category172.html0.2http://www.biotec.no/articles-of-association/vedtekter-for-biotec-pharmacon-asa-article165-172.html2010-06-15T10:38:48+02:000.2http://www.biotec.no/articles-of-association/articles-of-association-of-biotec-pharmacon-asa-article163-172.html2010-04-29T13:52:50+02:000.2http://www.biotec.no/general-meetings/category208.html0.2http://www.biotec.no/general-meetings/general-meetings-in-biotec-pharmacon-article275-208.html2010-05-05T08:56:57+02:000.2http://www.biotec.no/corporate-policies/category215.html0.2http://www.biotec.no/corporate-policies/aksjonaerpolitikk-og-utbyttepolitikk-article329-215.html2010-03-05T16:01:35+01:000.2http://www.biotec.no/corporate-policies/investor-relations-policy-article330-215.html2006-12-04T13:04:54+01:000.2http://www.biotec.no/corporate-policies/prinsipper-for-eierstyring-og-selskapsledelse-article327-215.html2010-04-29T13:17:15+02:000.2http://www.biotec.no/reports-and-presentations/category161.html0.2http://www.biotec.no/reports-and-presentations/reports-and-presentations-article504-161.html2010-04-12T14:37:46+02:000.2http://www.biotec.no/annual-reports/category162.html0.2http://www.biotec.no/annual-reports/biotec-pharmacon-annual-reports-article153-162.html2010-04-13T15:04:18+02:000.2http://www.biotec.no/quarterly-reports/category163.html0.2http://www.biotec.no/quarterly-reports/quarterly-reports-article154-163.html2010-08-09T23:03:19+02:000.2http://www.biotec.no/presentations/category164.html2009-09-04T08:21:52+02:000.2http://www.biotec.no/presentations/2nd-quarter-2010-presentation-article670-164.html2010-08-13T09:42:46+02:000.2http://www.biotec.no/presentations/1st-quarter-2010-presentation-article664-164.html2010-05-14T08:44:16+02:000.2http://www.biotec.no/news/biotec-pharmacon-presenting-re-established-platform-at-bio-europe-2010-article656-18.html2010-03-10T14:43:32+01:000.2http://www.biotec.no/presentations/4th-quarter-2009-presentation-article653-164.html2010-03-01T08:30:00+01:000.2http://www.biotec.no/presentations/presentations-archive-2009-article629-164.html2010-05-13T23:05:25+02:000.2http://www.biotec.no/presentations/presentations-archive-2008-and-earlier-article203-164.html2009-09-03T15:07:19+02:000.2http://www.biotec.no/prospectus/category165.html0.2http://www.biotec.no/prospectus/restrictions-relating-to-u-s-persons-article160-165.html2006-02-14T16:12:18+01:000.2http://www.biotec.no/analysts/category173.html0.2http://www.biotec.no/analysts/analysts-article164-173.html2009-04-14T15:01:47+02:000.2http://www.biotec.no/financial-calendar/category175.html2009-12-23T10:20:30+01:000.2http://www.biotec.no/financial-calendar/q2-2010-presentation-as-webcast-article669-175.html2010-08-05T12:49:25+02:000.2http://www.biotec.no/financial-calendar/q1-2010-presentation-as-webcast-article663-175.html2010-05-07T17:20:23+02:000.2http://www.biotec.no/financial-calendar/financial-calendar-2010-article648-175.html2010-04-29T13:55:02+02:000.2http://www.biotec.no/news/3q-presentation-as-webcast-article640-18.html2009-10-23T08:47:06+02:000.2http://www.biotec.no/subscribe/category179.html0.2http://www.biotec.no/subscribe/subscribe-to-news-from-biotec-pharmacon-article234-179.html2009-08-18T15:44:25+02:000.2http://www.biotec.no/vacancies/category122.html2010-06-24T15:52:05+02:000.2http://www.biotec.no/vacancies/vacant-positions-article668-122.html2010-06-24T15:52:34+02:000.2http://www.biotec.no/newsletter/category126.html2009-09-03T14:41:02+02:000.2http://www.biotec.no/newsletters/category125.html0.2http://www.biotec.no/newsletters/macrogard-a-feed-ingredient-or-a-feed-additive-article103-125.html2004-11-29T00:00:00+01:000.2http://www.biotec.no/newsletter-admin/category127.html0.2http://www.biotec.no/english/category373.html2009-08-25T14:38:46+02:000.2http://www.biotec.no/norwegian/category374.html2009-08-25T14:40:30+02:000.2http://www.biotec.no/special-elements/category14.html2009-09-03T14:44:58+02:000.2http://www.biotec.no/special-elements/cold-adapted-marine-enzymes-article59-14.html2003-09-23T00:00:00+02:000.2http://www.biotec.no/forgot-password/category19.html0.2http://www.biotec.no/lister/category119.html0.2http://www.biotec.no/lister/ir-contact-article199-119.html2005-11-07T16:10:09+01:000.2http://www.biotec.no/login/category128.html0.2http://www.biotec.no/no-category-access/category129.html0.2http://www.biotec.no/no-category-access/you-do-not-have-access-to-this-category-article104-129.html2004-12-01T00:00:00+01:000.2http://www.biotec.no/articles-banner/category327.html0.2http://www.biotec.no/newsarchive/category328.html0.2http://www.biotec.no/rss-feeds/category329.html0.2http://www.biotec.no/nyheter/category330.html0.2http://www.biotec.no/news/biotec-pharmacon-kommersiell-partner-i-senter-for-forskningsdrevet-innovasjon-i-tromsoe-article479-18.html2007-05-11T10:10:59+02:000.2